[CAS NO. 1796641-10-5]  Parimifasor

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1796641-10-5]

Catalog
HY-109098
Brand
MCE
CAS
1796641-10-5

DESCRIPTION [1796641-10-5]

Overview

MDL-
Molecular Weight460.21
Molecular FormulaC18H11Cl2F4N5O
SMILESO=C(C1=CC(Cl)=CC=C1)N/C(NC2=NNC(C(F)(F)F)=C2)=N/C3=CC(Cl)=CC(F)=C3

For research use only. We do not sell to patients.

Summary

Parimifasor (LYC30937) is an immunomodulator, with anti-inflammatory activity.


Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT02818543 Lycera Corp.
Ulcerative Colitis
March 2016 Phase 1

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 66.67 mg/mL ( 144.87 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1729 mL 10.8646 mL 21.7292 mL
5 mM 0.4346 mL 2.1729 mL 4.3458 mL
10 mM 0.2173 mL 1.0865 mL 2.1729 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: 2.5 mg/mL (5.43 mM); Suspended solution; Need ultrasonic

* All of the co-solvents are available by MCE.